Letermovir Tablets 480mg

Letermovir Tablets 480mgTechnical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

A) Letermovir Tablets 240mg
B) Letermovir Tablets 480mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A) Letermovir Tablets 240mg
Each film coated tablet contains:
Letermovir ………………………………………….240mg
Excipients…………………………………………….q.s.
Colourant: Titanium Dioxide USP, Alura Red AC
Aluminium lake: Brilliant Blue FCF Aluminium lake

B) Letermovir Tablets 480mg
Each film coated tablet contains:
Letermovir ………………………………………….480mg
Excipients…………………………………………….q.s.
Colourant: Titanium Dioxide USP, Alura Red AC
Aluminium lake: Brilliant Blue FCF Aluminium lake

THERAPEUTIC INDICATIONS:

prophylaxis (prevention) of cytomegalovirus (CMV) infection and disease in specific high-risk transplant patients.

CAUTION & WARNING:

CAUTION: Administer orally with or without food. Swallow tablets whole.

WARNING: To be sold by retail on the prescription of specialists in organ transplant, infectious disease, hematologist

STORAGE & DOSAGE:

Storage: Storage below 25°C For Oral Administration only
KEEP OUT OF REACH OF CHILDREN.

Dosage: As directed by the Physician

Introduction to Letermovir Tablets 480mg

Letermovir Tablets 480mg contain letermovir, a specialized antiviral medicine used for the prevention of cytomegalovirus (CMV) reactivation and disease in eligible transplant recipients. CMV can remain dormant in the body and become active when the immune system is weakened, particularly following transplantation. Regulatory information identifies letermovir for CMV prophylaxis in appropriate recipients of an allogeneic hematopoietic stem cell transplant (HSCT) and certain high-risk kidney-transplant recipients.

Taj Medico is positioned as a Letermovir Tablets 480mg Manufacturer in India, supplier, and exporter associated with Vapi, Gujarat. We serve pharmaceutical importers, distributors, institutional procurement organizations, and other qualified buyers seeking specialized pharmaceutical products for domestic and international markets.

The 480mg tablet is an important presentation of letermovir. Current European product information identifies a 480mg film-coated tablet containing 480mg of letermovir. For certain eligible transplant patients, the recommended dose is 480mg once daily, while the dose is reduced when letermovir is co-administered with cyclosporine.

Letermovir Tablets 480mg Manufacturer in India

As a Letermovir Tablets 480mg Supplier, we understand that pharmaceutical buyers require more than a product listing. They need consistent product specifications, quality-focused manufacturing, suitable packaging, documentation, professional communication, and dependable logistics.

Letermovir belongs to the antiviral class and has a highly specific therapeutic application. It should not be described as a medicine for herpes labialis, genital herpes, chickenpox, herpes simplex eye infections, or chronic hepatitis C. Its established regulatory role is CMV prophylaxis in specified transplant populations.

This distinction is important for pharmaceutical websites, distributors, importers, and healthcare-sector buyers because accurate product information supports responsible procurement and regulatory compliance.

How Does Letermovir 480mg Work?

Letermovir has a distinctive mechanism of action. It blocks the CMV DNA terminase complex, a viral system required for processing and packaging CMV DNA into newly formed viral particles.

When this process is inhibited, CMV cannot efficiently produce properly packaged infectious particles. This helps prevent CMV from becoming active and causing disease in appropriate high-risk patients. The EMA explains that letermovir blocks terminase, preventing CMV from developing properly and reducing its ability to multiply and infect other cells.

This mechanism makes letermovir different from antiviral medicines that act on viral DNA polymerase. Its specialized mechanism is one reason it has become an important product in CMV prevention strategies for eligible transplant recipients.

Who Uses Letermovir Tablets 480mg?

The approved patient population depends on the regulatory jurisdiction and the specific product labeling. Under current EMA information, letermovir is indicated for prophylaxis of CMV reactivation and disease in eligible CMV-seropositive recipients of an allogeneic HSCT. It is also indicated for CMV disease prophylaxis in eligible high-risk kidney-transplant recipients.

In kidney-transplant recipients weighing at least 40kg, the EMA product information specifies 480mg once daily, with reduction to 240mg once daily when co-administered with cyclosporine.

Because transplant patients often receive several medicines simultaneously, prescribing decisions must be made by qualified healthcare professionals who can assess transplant status, CMV risk, concomitant medicines, organ function, and the applicable approved labeling.

Technical Product Specification of Letermovir Tablets 480mg

The exact product specification, storage conditions, shelf life, packaging configuration, and documentation should always be confirmed against the applicable approved product information and batch-specific documentation.

Regulatory Documentation for Importers and Exporters

International pharmaceutical procurement requires careful documentation. Depending on the destination market, buyers may require a Certificate of Analysis (COA), product specifications, manufacturing documentation, stability information, batch documentation, packaging information, and certificates relevant to the importing country’s regulatory framework.

For registration purposes, certain markets may request a CTD or eCTD dossier, while other markets may use different technical submission formats. A Certificate of Pharmaceutical Product (COPP) may also be requested where applicable.

References to WHO-GMP, EU-GMP, COPP, CTD dossiers, or other certifications must correspond to the actual facility, product, and regulatory documentation available for the particular supply arrangement. Buyers should conduct their own regulatory due diligence before importation.

Custom Packaging and Labeling for Letermovir 480mg

International pharmaceutical buyers may require customized packaging based on the regulations of their destination country. Requirements can include importer information, registration numbers, local-language labeling, batch number, manufacturing date, expiry date, storage conditions, statutory information, and other market-specific particulars.

We can discuss custom packaging and labeling requirements with prospective buyers before commercial confirmation. Final artwork should comply with the approved product information and the applicable regulatory requirements of the destination country.

Shelf Life, Storage, and Product Handling

Shelf life should be confirmed from the specific batch documentation and approved product labeling rather than assumed from a general online description.

Proper storage and transportation are essential to maintaining pharmaceutical quality throughout the supply chain. Warehouses, distributors, and importers should maintain the conditions specified on the applicable product label and documentation.

Our approach to pharmaceutical supply considers product handling, packaging integrity, documentation, shipment planning, and communication throughout the procurement process.

Why Choose Taj Medico as a Letermovir Tablets 480mg Supplier?

Taj Medico is positioned as a Letermovir Tablets 480mg Manufacturer in India, supplier, and exporter from Vapi, Gujarat. We focus on creating dependable pharmaceutical supply relationships with domestic and international buyers.

Our supply approach emphasizes:

• Quality-focused pharmaceutical manufacturing
• Controlled production and quality processes
• Consistent product specifications
• Professional pharmaceutical packaging
• Export-oriented supply coordination
• Documentation support according to applicable requirements
• Market-specific labeling discussions
• Competitive commercial opportunities
• Reliable buyer communication
• Long-term distributor and importer relationships

We understand that global pharmaceutical procurement requires coordination across manufacturing, documentation, regulatory requirements, logistics, and commercial planning.

State-of-the-Art Pharmaceutical Manufacturing Approach

Modern pharmaceutical manufacturing requires systematic control of raw materials, production processes, testing, packaging, storage, and documentation.

As a pharmaceutical supplier associated with Vapi, Gujarat, we focus on maintaining a professional manufacturing and supply environment designed to support consistent pharmaceutical procurement.

For buyers evaluating a WHO-GMP manufacturer in India, the appropriate approach is to verify current certificates, scope, validity, manufacturing site, and product applicability rather than relying solely on marketing terminology.

Affordable Pricing and Quality Assurance

Price is an important consideration for pharmaceutical importers, but the lowest quotation does not necessarily represent the best overall procurement value.

A professional buyer should evaluate product quality, specifications, documentation, packaging, regulatory suitability, supply consistency, lead time, and after-sales coordination alongside price.

We aim to provide commercially competitive pharmaceutical supply solutions while maintaining attention to quality and documentation requirements.

Letermovir Tablets 480mg PAN India Manufacturer

Indian buyers searching for a Letermovir Tablets 480mg PAN India Manufacturer, supplier, or pharmaceutical distributor can approach Taj Medico for current product and commercial information.

We can coordinate inquiries from pharmaceutical markets throughout India, including Mumbai, Maharashtra, and other major distribution centers.

Searches such as Letermovir Tablets 480mg Manufacturer from Mumbai, Letermovir Tablets 480mg in Mumbai Maharashtra, and Letermovir Tablets 480mg Best Price in Mumbai represent common procurement requirements. Actual availability, pricing, packaging, and distribution arrangements should be confirmed directly based on current supply conditions.

Letermovir Tablets 480mg PCD Pharma Franchise

Businesses searching for Letermovir Tablets 480mg Manufacturer Supplier and PCD Pharma Franchise opportunities should first evaluate the regulatory and commercial suitability of the product for their proposed territory.

Because letermovir is a specialized prescription antiviral, marketing and distribution must comply with applicable pharmaceutical regulations. Any franchise arrangement should consider product registration, promotional restrictions, territory requirements, licensing, and approved indications.

Qualified pharmaceutical businesses can discuss their distribution requirements and intended markets with our team.

Letermovir Tablets 480mg Export from India

India is a major pharmaceutical manufacturing and export hub, offering international buyers access to a broad ecosystem of pharmaceutical production and supply services.

A successful Letermovir Tablets 480mg export from India requires coordination of product specifications, documentation, packaging, regulatory requirements, customs procedures, shipping arrangements, and destination-market compliance.

We work with international pharmaceutical buyers seeking structured and reliable sourcing from India, subject to applicable regulatory authorization and product availability.

Top 20 Countries and Export Markets

Our international supply strategy can support pharmaceutical buyers evaluating opportunities across the following markets:

South Africa, Kenya, Nigeria, Ghana, Tanzania, Uganda, Ethiopia, Zambia, Zimbabwe, United Arab Emirates, Saudi Arabia, Oman, Qatar, Bangladesh, Nepal, Sri Lanka, Myanmar, Vietnam, Philippines, and Cambodia.

Each destination has its own requirements for pharmaceutical registration, import licensing, labeling, customs clearance, pharmacovigilance, and distribution. Export arrangements therefore need to be evaluated individually.

Safety Information and Common Adverse Effects

Letermovir is a prescription antiviral and should be taken according to the instructions of a qualified healthcare professional.

The EMA identifies nausea, diarrhoea, and vomiting among the common adverse effects. Other reactions can occur, and clinically important drug interactions must be considered.

Letermovir can interact with other medicines, and cyclosporine is particularly important because it affects the recommended letermovir dose. Patients should provide their healthcare professional with a complete list of prescription medicines, over-the-counter products, and supplements before starting treatment.

Treatment should not be started, stopped, or dose-adjusted without appropriate medical advice.

Top 20 FAQs About Letermovir Tablets 480mg

1. What are Letermovir Tablets 480mg?

They are film-coated oral tablets containing 480mg of letermovir, an antiviral medicine used for CMV prophylaxis in specified transplant populations.

2. What is letermovir primarily used for?

It is used to prevent CMV reactivation and disease in eligible transplant recipients.

3. Is letermovir an antibiotic?

No. Letermovir is an antiviral medicine.

4. Is letermovir used for herpes simplex?

Its established indication is CMV prophylaxis, not routine treatment of herpes simplex infections.

5. How does letermovir work?

It inhibits the CMV terminase complex involved in viral DNA processing and packaging.

6. What is the usual 480mg regimen?

For eligible patients, the approved regimen can be 480mg once daily, depending on the indication and concomitant medicines.

7. When is the dose reduced to 240mg?

The dose is reduced to 240mg once daily when letermovir is co-administered with cyclosporine under the applicable product information.

8. Can letermovir be used after kidney transplantation?

Yes, approved labeling includes CMV prophylaxis for specified high-risk kidney-transplant recipients.

9. Can letermovir be used after stem cell transplantation?

Yes, it is indicated for CMV prophylaxis in appropriate allogeneic HSCT recipients.

10. Who manufactures Letermovir Tablets 480mg in India?

Taj Medico is positioned as a manufacturer and supplier from Vapi, Gujarat, subject to applicable product and regulatory availability.

11. Can Letermovir Tablets 480mg be exported from India?

Export opportunities depend on product availability, destination-country authorization, documentation, and applicable pharmaceutical regulations.

12. Can buyers request customized packaging?

Yes, packaging and labeling requirements can be discussed according to destination-market requirements.

13. What documents may importers request?

Documents can include COA, product specifications, batch documentation, manufacturing information, and market-specific regulatory certificates where applicable.

14. Is a CTD dossier always required?

No. CTD requirements depend on the regulatory authority and the purpose of the submission.

15. Is WHO-GMP important for pharmaceutical buyers?

GMP compliance is an important consideration when evaluating pharmaceutical manufacturing facilities and suppliers.

16. What are common adverse effects of letermovir?

Nausea, diarrhoea, and vomiting are among the commonly reported adverse effects.

17. Can letermovir interact with other medicines?

Yes. Drug interactions are clinically important, particularly with certain medicines used in transplant patients.

18. How should Letermovir Tablets 480mg be stored?

Storage should follow the approved product labeling and batch-specific documentation.

19. Can Taj Medico supply pharmaceutical distributors?

Qualified pharmaceutical distributors and importers can contact Taj Medico to discuss product availability and commercial requirements.

20. How can global buyers contact Taj Medico?

International buyers can contact the Taj Medico team using the business contact details provided below with their required quantity, destination country, packaging requirements, and documentation needs.

Contact Taj Medico for Letermovir Tablets 480mg Supply

For pharmaceutical importers, distributors, institutional buyers, and companies seeking a Letermovir Tablets 480mg Manufacturer in India, Taj Medico provides a dedicated point of contact for discussing sourcing requirements.

Taj Medico Ltd.
Mobile / WhatsApp Support: +91 74 0000 9975 / +91 74 0000 9976
Email: info@tajpharma.com

When contacting us, buyers can include the required quantity, destination country, preferred packaging, registration status, and documentation requirements to help streamline the quotation and supply discussion.

Letermovir Tablets 480mg are a specialized antiviral product used for prevention of CMV reactivation and disease in eligible transplant populations. Current regulatory information confirms its role in CMV prophylaxis following allogeneic HSCT and in specified high-risk kidney-transplant recipients.

Taj Medico is positioned as a Letermovir Tablets 480mg Manufacturer in India, supplier, and exporter associated with Vapi, Gujarat. We focus on quality-oriented pharmaceutical supply, professional documentation, packaging coordination, export support, and long-term relationships with global pharmaceutical buyers.

For organizations searching for Letermovir Tablets 480mg Manufacturer in India, Letermovir Tablets 480mg Supplier, Letermovir Tablets 480mg export from India, or a WHO-GMP manufacturer in India, Taj Medico can be contacted to discuss current product availability, specifications, quantities, packaging, regulatory requirements, and international supply opportunities.